Lenalidomide: An Alternative Treatment for Refractory Behçet's Disease and Relapsing Polychondritis (Q91786321)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

title

Lenalidomide: An Alternative Treatment for Refractory Behçet's Disease and Relapsing Polychondritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

relapsing polychondritis

1 reference

Sofia Gomes Brazão

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

Jorge Crespo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

Armando Carvalho

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

publication date

31 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

European journal of case reports in internal medicine

24 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

page(s)

001117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

Lenalidomide for treatment of recurrent oral aphthae in Adamantiades-Behçet's disease

24 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Mouth and Genital Ulcers with Inflamed Cartilage Syndrome: Case Report and Review of the Published Work.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Pulmonary Sarcoidosis Induced by Adalimumab: A Case Report and Literature Review

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Successful management of refractory pediatric-onset complex aphthosis with lenalidomide

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

[Current therapeutic indications of thalidomide and lenalidomide].

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Treatment of refractory prurigo nodularis with lenalidomide

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Lenalidomide therapy in treatment-refractory cutaneous lupus erythematosus: Histologic and circulating leukocyte profile and potential risk of a systemic lupus flare

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

A review of the history, properties, and use of the immunomodulatory compound lenalidomide

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Successful treatment of Behçet's disease with lenalidomide

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Lenalidomide and thalidomide: mechanisms of action--similarities and differences

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease

23 February 2021

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6601695

23 February 2021

Identifiers

DOI

10.12890/2019_001117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31293992 AND SRC:MED&resulttype=core&format=json

24 April 2020

PubMed publication ID

31293992

1 reference